These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9217410)

  • 1. Buspirone in the management of disruptive behaviors due to Huntington's disease and other neurological disorders.
    Bhandary AN; Masand PS
    Psychosomatics; 1997; 38(4):389-91. PubMed ID: 9217410
    [No Abstract]   [Full Text] [Related]  

  • 2. Possible role of buspirone hydrochloride in smoking cessation.
    Bevelaqua FA
    Chest; 1997 Nov; 112(5):1445-6. PubMed ID: 9367495
    [No Abstract]   [Full Text] [Related]  

  • 3. Graft-induced dyskinesias fail to respond to 5HT1A agonist in the long-term.
    Beaulieu-Boire I; Fasano A
    Mov Disord; 2015 May; 30(6):872-3. PubMed ID: 25758209
    [No Abstract]   [Full Text] [Related]  

  • 4. Increased prolactin response to buspirone in chronic fatigue syndrome.
    Sharpe M; Clements A; Hawton K; Young AH; Sargent P; Cowen PJ
    J Affect Disord; 1996 Nov; 41(1):71-6. PubMed ID: 8938208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effects of buspirone therapy in Huntington's disease.
    Byrne A; Martin W; Hnatko G
    Am J Psychiatry; 1994 Jul; 151(7):1097. PubMed ID: 8010374
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of Low-Dose Buspirone for Restricted and Repetitive Behavior in Young Children with Autism Spectrum Disorder: A Randomized Trial.
    Chugani DC; Chugani HT; Wiznitzer M; Parikh S; Evans PA; Hansen RL; Nass R; Janisse JJ; Dixon-Thomas P; Behen M; Rothermel R; Parker JS; Kumar A; Muzik O; Edwards DJ; Hirtz D;
    J Pediatr; 2016 Mar; 170():45-53.e1-4. PubMed ID: 26746121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Buspirone for anxiety and agitation in dementia.
    Cooper JP
    J Psychiatry Neurosci; 2003 Nov; 28(6):469. PubMed ID: 14631458
    [No Abstract]   [Full Text] [Related]  

  • 8. Repurposing buspirone for drug addiction treatment.
    Le Foll B; Boileau I
    Int J Neuropsychopharmacol; 2013 Mar; 16(2):251-3. PubMed ID: 23174122
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of aggression in juvenile-onset Huntington's disease with buspirone.
    Findling RL
    Psychosomatics; 1993; 34(5):460-1. PubMed ID: 8140199
    [No Abstract]   [Full Text] [Related]  

  • 10. Buspirone for stereotypic movements in elderly with cognitive impairment.
    Helvink B; Holroyd S
    J Neuropsychiatry Clin Neurosci; 2006; 18(2):242-4. PubMed ID: 16720804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Buspirone treatment of cannabis dependence: A randomized, placebo-controlled trial.
    McRae-Clark AL; Baker NL; Gray KM; Killeen TK; Wagner AM; Brady KT; DeVane CL; Norton J
    Drug Alcohol Depend; 2015 Nov; 156():29-37. PubMed ID: 26386827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of cerebellar ataxia with buspirone: a double-blind study.
    Trouillas P; Xie J; Adeleine P
    Lancet; 1996 Sep; 348(9029):759. PubMed ID: 8806320
    [No Abstract]   [Full Text] [Related]  

  • 13. Buspirone in primary headaches.
    Pascual J; Berciano J
    Acta Neurol Scand; 1998 Feb; 97(2):142. PubMed ID: 9517866
    [No Abstract]   [Full Text] [Related]  

  • 14. Quetiapine in the treatment of behavioral disturbances in patients with Huntington's disease.
    Alpay M; Koroshetz WJ
    Psychosomatics; 2006; 47(1):70-2. PubMed ID: 16384811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative treatment for poststroke depression.
    Mårtensson B; Murray V; von Arbin M; Asberg M; Bartfai A; Malm K
    Am J Psychiatry; 1997 Apr; 154(4):583-4. PubMed ID: 9090359
    [No Abstract]   [Full Text] [Related]  

  • 16. Buspirone and brain injury.
    Holzer JC
    J Neuropsychiatry Clin Neurosci; 1998; 10(1):113. PubMed ID: 9547478
    [No Abstract]   [Full Text] [Related]  

  • 17. Huntington's disease and propranolol.
    Stewart JT
    Am J Psychiatry; 1993 Jan; 150(1):166-7. PubMed ID: 8417564
    [No Abstract]   [Full Text] [Related]  

  • 18. Neuropsychiatry of Huntington's disease and other basal ganglia disorders.
    Rosenblatt A; Leroi I
    Psychosomatics; 2000; 41(1):24-30. PubMed ID: 10665265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Buspirone: what is it all about?
    Loane C; Politis M
    Brain Res; 2012 Jun; 1461():111-8. PubMed ID: 22608068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Huntington's disease: a negative family history case report demonstrating reduction of psychiatric symptoms with olanzapine].
    Coelho VA; Beato RG; Prado PH; Cardoso FE; Lauar H
    Braz J Psychiatry; 2009 Jun; 31(2):186-8. PubMed ID: 19578696
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.